Back
Atossa Therapeutics, Inc. 10K Form
Sell
35
ATOS
Atossa Therapeutics, Inc.
Last Price:
$0.76
Seasonality Move:
-36.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATOS News And Ratings
See the #1 stock for the next 7 days that we like better than ATOS
ATOS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.39 |
| Price / Book: | 1.97 |
Profitability
| EPS (TTM): | -0.23460 |
|---|---|
| Net Income (TTM): | $-30.2M |
| Gross Margin: | $-17K |
| Return on Equity: | -47.46% |
| Return on Assets: | -43.21% |
Atossa Therapeutics, Inc. Earnings Forecast
Key Atossa Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 15 years have been positive in 9 years.
Atossa Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATOS |
| CUSIP: | 04962H |
| Website: | atossatherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.77 |
| Quick Ratio: | 6.32 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATOS Technical Analysis vs Fundamental Analysis
Sell
35
Atossa Therapeutics, Inc. (ATOS)
is a Sell
Is Atossa Therapeutics, Inc. a Buy or a Sell?
-
Atossa Therapeutics, Inc. stock is rated a SellThe current Atossa Therapeutics, Inc. [ATOS] share price is $0.76. The Score for ATOS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.